Show simple item record

Authordc.contributor.authorValdés, Pamela 
Authordc.contributor.authorMercado, Gabriela es_CL
Authordc.contributor.authorVidal, René L. es_CL
Authordc.contributor.authorMolina, Claudia es_CL
Authordc.contributor.authorParsons, Geoffrey es_CL
Authordc.contributor.authorCourt, Felipe A. es_CL
Authordc.contributor.authorMartínez, Alexis es_CL
Authordc.contributor.authorGalleguillos, Danny es_CL
Authordc.contributor.authorArmentano, Donna es_CL
Authordc.contributor.authorSchneider, Bernard L. es_CL
Authordc.contributor.authorHetz Flores, Claudio es_CL
Admission datedc.date.accessioned2014-12-18T17:48:39Z
Available datedc.date.available2014-12-18T17:48:39Z
Publication datedc.date.issued2014
Cita de ítemdc.identifier.citationPNAS | May 6, 2014 | vol. 111 | no. 18en_US
Identifierdc.identifier.otherDOI: 10.1073/pnas.1321845111
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/129424
General notedc.descriptionArtículo de publicación ISIen_US
Abstractdc.description.abstractParkinson disease (PD) is characterized by the selective loss of dopaminergic neurons of the substantia nigra pars compacta (SNpc). Although growing evidence indicates that endoplasmic reticulum (ER) stress is a hallmark of PD, its exact contribution to the disease process is not well understood. Here we report that developmental ablation of X-Box binding protein 1 (XBP1) in the nervous system, a key regulator of the unfolded protein response (UPR), protects dopaminergic neurons against a PD-inducing neurotoxin. This survival effect was associated with a preconditioning condition that resulted from induction of an adaptive ER stress response in dopaminergic neurons of the SNpc, but not in other brain regions. In contrast, silencing XBP1 in adult animals triggered chronic ER stress and dopaminergic neuron degeneration. Supporting this finding, gene therapy to deliver an active form of XBP1 provided neuroprotection and reduced striatal denervation in animals injected with 6-hydroxydopamine. Our results reveal a physiological role of the UPR in the maintenance of protein homeostasis in dopaminergic neurons that may help explain the differential neuronal vulnerability observed in PD.en_US
Patrocinadordc.description.sponsorshipThis work was funded primarily by the Michael J. Fox Foundation for Parkinson’s Research, Fondo de Fomento al Desarrollo Científico y Tecnológico D11I1007, Millennium Institute P09-015-F, Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT) 1140549 (to C.H.), FONDECYT 3120146 (to G.M.), Comisión Nacional de Investigación Científica y Tecnológica (CONICYT) Capital Humano en la Academia 7912010006 (to R.L.V.), and Ring Initiative ACT1109 (to C.H. and F.A.C.). Funding was also provided by Comité de Evaluación y Orientación de la Cooperación Científica con Chile del Gobierno de Francia-CONICYT C13S02, CONICYT Grant USA2013-0003, the Muscular Dystrophy Association, the ALS Therapy Alliance, and the Alzheimer Association (C.H.). P.V., C.M., and A.M. are doctoral fellows supported by a CONICYT fellowship and CONICYT Research Grant AT- 24100179). F.A.C. is supported by FONDECYT 1110987 and Millennium Nucleus P07-011-F. B.L.S. is supported by the Swiss National Science Foundation (Grant 31003A_135696).en_US
Lenguagedc.language.isoenen_US
Publisherdc.publisherCrossMarken_US
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Títulodc.titleControl of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1en_US
Document typedc.typeArtículo de revista


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile